The Arg282Ser missense mutation in APOA5 gene determines a reduction of triglyceride and LDL-cholesterol in children, together with low serum levels of apolipoprotein A-V
暂无分享,去创建一个
A. Lenzi | S. Loche | I. Barchetta | M. Cavallo | M. Baroni | F. Sentinelli | M. Incani | E. Cossu | F. A. Cimini | L. Bertoccini | D. Bailetti
[1] S. Morini,et al. The vitamin D receptor (VDR) gene rs11568820 variant is associated with type 2 diabetes and impaired insulin secretion in Italian adult subjects, and associates with increased cardio-metabolic risk in children. , 2016, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[2] Alan M. Kwong,et al. Genome sequencing elucidates Sardinian genetic architecture and augments association analyses for lipid and blood inflammatory markers , 2015, Nature Genetics.
[3] Xi-Long Zheng,et al. Lipoprotein lipase: from gene to atherosclerosis. , 2014, Atherosclerosis.
[4] B. Melegh,et al. Mutations of the apolipoprotein A5 gene with inherited hypertriglyceridaemia: review of the current literature. , 2012, Current medicinal chemistry.
[5] M. Guardiola,et al. APOA5 gene expression in the human intestinal tissue and its response to in vitro exposure to fatty acid and fibrate. , 2012, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[6] G. Olivecrona,et al. Apolipoprotein A-V; a potent triglyceride reducer. , 2011, Atherosclerosis.
[7] S. Kathiresan,et al. Genetic determinants of plasma triglycerides , 2011, Journal of Lipid Research.
[8] S. Mariotti,et al. Oral glucose tolerance test in Italian overweight/obese children and adolescents results in a very high prevalence of impaired fasting glycaemia, but not of diabetes , 2009, Diabetes/metabolism research and reviews.
[9] R. D'Agostino,et al. A genome-wide association study for blood lipid phenotypes in the Framingham Heart Study , 2007, BMC Medical Genetics.
[10] P. Talmud,et al. Evidence for a complex relationship between apoA-V and apoC-III in patients with severe hypertriglyceridemia Published, JLR Papers in Press, July 21, 2006. , 2006, Journal of Lipid Research.
[11] P. Talmud,et al. Apolipoprotein A-V, triglycerides and risk of coronary artery disease: the prospective Epic-Norfolk Population Study Published, JLR Papers in Press, June 12, 2006. , 2006, Journal of Lipid Research.
[12] P. Talmud,et al. The apolipoprotein A-V genotype and plasma apolipoprotein A-V and triglyceride levels: prospective risk of type 2 diabetes. Results from the Northwick Park Heart Study II , 2006, Diabetologia.
[13] E. Spada,et al. Italian cross-sectional growth charts for height, weight and BMI (2 to 20 yr) , 2006, Journal of endocrinological investigation.
[14] E. Sijbrands,et al. Plasma apolipoprotein A5 and triglycerides in type 2 diabetes , 2006, Diabetologia.
[15] J. Pitha,et al. APOA5 variant Ser19Trp influences a decrease of the total cholesterol in a male 8 year cohort. , 2006, Clinical biochemistry.
[16] David W. Williamson,et al. Apolipoprotein A-V: a potential modulator of plasma triglyceride levels in Turkss⃞ , 2006, Journal of Lipid Research.
[17] K. Chien,et al. A novel genetic variant in the apolipoprotein A5 gene is associated with hypertriglyceridemia. , 2003, Human molecular genetics.
[18] C. Kay,et al. Structure-function studies of human apolipoprotein A-V: a regulator of plasma lipid homeostasis. , 2003, Biochemistry.
[19] Jonathan C. Cohen,et al. Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels. , 2002, Human molecular genetics.
[20] R. Chamuleau,et al. Adenoviral overexpression of apolipoprotein A-V reduces serum levels of triglycerides and cholesterol in mice. , 2002, Biochemical and biophysical research communications.
[21] P. Reitsma,et al. Apolipoprotein A-V , 2001, The Journal of Biological Chemistry.
[22] Jonathan C. Cohen,et al. An Apolipoprotein Influencing Triglycerides in Humans and Mice Revealed by Comparative Sequencing , 2001, Science.
[23] R. Turner,et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.
[24] K. Lackner,et al. Apolipoprotein A-V , 2019, Springer Reference Medizin.
[25] K. V. van Dijk,et al. Plasma apoAV levels are markedly elevated in severe hypertriglyceridemia and positively correlated with the APOA5 S19W polymorphism. , 2007, Atherosclerosis.